Protagonist Therapeutics, Inc. (PTGX) on GreekSoup https://greeksoup.ai/stocks/us/ptgx/ Every dated entry in the public record on Protagonist Therapeutics, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Mon, 12 Oct 2026 00:00:00 +0000 Protagonist Therapeutics, Inc.: Ali Asif (Chief Financial Officer) sold 12,595 shares at $141.77 on 30 September 2026, $1.8 millionhttps://greeksoup.ai/stocks/us/ptgx/insiders/us:PTGX:insider:2026-10-02:25f6fed904Fri, 02 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Protagonist Therapeutics, Inc.: Ali Asif (Chief Financial Officer) sold 46,034 shares at $141.78 on 30 September 2026, $6.5 millionhttps://greeksoup.ai/stocks/us/ptgx/insiders/us:PTGX:insider:2026-10-02:3dc761a10cFri, 02 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Protagonist Therapeutics, Inc.: Form 144, ASIF ALI plans to sell 58,629 shares worth $8.3 million around 30 September 2026https://greeksoup.ai/stocks/us/ptgx/planned-sales/us:PTGX:planned-sale:2026-09-30:a379f9a610Wed, 30 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Protagonist Therapeutics, Inc.: short interest 9,345,382 shares at the 30 September 2026 settlement, 11.49 days to coverhttps://greeksoup.ai/stocks/us/ptgx/short-interest/us:PTGX:short-interest:2026-09-30:21f1862729Wed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Protagonist Therapeutics, Inc.: short interest 8,140,194 shares at the 15 September 2026 settlement, 15.13 days to coverhttps://greeksoup.ai/stocks/us/ptgx/short-interest/us:PTGX:short-interest:2026-09-15:c279626aecTue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Protagonist Therapeutics, Inc.: Patel Dinesh V Ph D (President and CEO) sold 7,278 shares at $144.10 on 10 September 2026, $1.0 millionhttps://greeksoup.ai/stocks/us/ptgx/insiders/us:PTGX:insider:2026-09-10:b4030c56cdThu, 10 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Protagonist Therapeutics, Inc.: Patel Dinesh V Ph D (President and CEO) sold 63,548 shares at $146.18 on 9 September 2026, $9.3 millionhttps://greeksoup.ai/stocks/us/ptgx/insiders/us:PTGX:insider:2026-09-10:594de8113fThu, 10 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Protagonist Therapeutics, Inc.: Patel Dinesh V Ph D (President and CEO) sold 54,174 shares at $145.87 on 8 September 2026, $7.9 millionhttps://greeksoup.ai/stocks/us/ptgx/insiders/us:PTGX:insider:2026-09-10:2ed5326923Thu, 10 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Protagonist Therapeutics, Inc.: short interest 7,712,543 shares at the 31 August 2026 settlement, 15.34 days to coverhttps://greeksoup.ai/stocks/us/ptgx/short-interest/us:PTGX:short-interest:2026-08-31:e36d0ba96fMon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Protagonist Therapeutics, Inc.: short interest 7,791,795 shares at the 14 August 2026 settlement, 16.42 days to coverhttps://greeksoup.ai/stocks/us/ptgx/short-interest/us:PTGX:short-interest:2026-08-14:5efc586c81Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Protagonist Therapeutics, Inc.: Schedule 13G/A filed by Farallon Capital Management, L.L.C., 10.0% of the classhttps://greeksoup.ai/stocks/us/ptgx/holders/us:PTGX:schedule-13:2026-08-13:f7726f4085Thu, 13 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Protagonist Therapeutics, Inc.: Patel Dinesh V Ph D (President and CEO) sold 34,239 shares at $148.52 on 11 August 2026, $5.1 millionhttps://greeksoup.ai/stocks/us/ptgx/insiders/us:PTGX:insider:2026-08-12:313dae4ae6Wed, 12 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Protagonist Therapeutics, Inc.: Patel Dinesh V Ph D (President and CEO) sold 65,761 shares at $149.11 on 10 August 2026, $9.8 millionhttps://greeksoup.ai/stocks/us/ptgx/insiders/us:PTGX:insider:2026-08-12:7018b46f78Wed, 12 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Protagonist Therapeutics, Inc.: Form 144, Dinesh Patel plans to sell 225,000 shares worth $33.6 million around 10 August 2026https://greeksoup.ai/stocks/us/ptgx/planned-sales/us:PTGX:planned-sale:2026-08-10:5722ad0cd6Mon, 10 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Protagonist Therapeutics, Inc.: Schedule 13G filed by STATE STREET CORPORATION, 5.2% of the classhttps://greeksoup.ai/stocks/us/ptgx/holders/us:PTGX:schedule-13:2026-08-07:5e8448f4aaFri, 07 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Protagonist Therapeutics, Inc. Q2 FY2026 results: revenue $213 million, net income $163 millionhttps://greeksoup.ai/stocks/us/ptgx/results/fy2026-q2/us:PTGX:result:2026-08-05:11a5a03a86Wed, 05 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Protagonist Therapeutics, Inc. filed S-8: form s-8https://greeksoup.ai/stocks/us/ptgx/filings/us:PTGX:filing:2026-08-05:1a43c122f8Wed, 05 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Protagonist Therapeutics, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/ptgx/filings/us:PTGX:filing:2026-08-05:69f6c5ac6bWed, 05 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Protagonist Therapeutics, Inc. filed 8-K: results of operations, regulation fd disclosurehttps://greeksoup.ai/stocks/us/ptgx/filings/us:PTGX:filing:2026-08-05:7e420dcc3eWed, 05 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Protagonist Therapeutics, Inc.: short interest 7,543,109 shares at the 31 July 2026 settlement, 14.21 days to coverhttps://greeksoup.ai/stocks/us/ptgx/short-interest/us:PTGX:short-interest:2026-07-31:772581295eFri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Protagonist Therapeutics, Inc.: short interest 8,292,656 shares at the 15 July 2026 settlement, 9.53 days to coverhttps://greeksoup.ai/stocks/us/ptgx/short-interest/us:PTGX:short-interest:2026-07-15:cce3d5335eWed, 15 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]>